Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting

Armand Sprecher, Robert Cross, Andrea Marzi, Karen A. Martins, Daniel Wolfe, Joel M. Montgomery, Christina F. Spiropoulou, Tomas Cihlar, Steve Ahuka-Mundeke, Tara Nyhuis, Carrie Teicher, Ian Crozier, Jim Strong, Gary Kobinger, Courtney Woolsey, Thomas W. Geisbert, Heinz Feldmann, Jean Jacques Muyembe

Research output: Contribution to journalArticlepeer-review


Although there are now approved treatments and vaccines for Ebola virus disease, the case fatality rate remains unacceptably high even when patients are treated with the newly approved therapeutics. Furthermore, these countermeasures are not expected to be effective against disease caused by other filoviruses. A meeting of subject-matter experts was held during the 10th International Filovirus Symposium to discuss strategies to address these gaps. Several investigational therapeutics, vaccine candidates, and combination strategies were presented. The greatest challenge was identified to be the implementation of well-designed clinical trials of safety and efficacy during filovirus disease outbreaks. Preparing for this will require agreed-upon common protocols for trials intended to bridge multiple outbreaks across all at-risk countries. A multinational research consortium including at-risk countries would be an ideal mechanism to negotiate agreement on protocol design and coordinate preparation. Discussion participants recommended a follow-up meeting be held in Africa to establish such a consortium.

Original languageEnglish (US)
Pages (from-to)S474-S478
JournalJournal of Infectious Diseases
StatePublished - Nov 15 2023


  • clinical trials
  • disease outbreaks
  • filoviruses
  • therapeutics
  • vaccines

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting'. Together they form a unique fingerprint.

Cite this